Distinct structural abnormalities of chromosomes 11 and 12 associated with loss of heterozygosity in X-ray-induced mouse thymic lymphomas

Cancer Genetics and Cytogenetics

Volumn 179, Issue 1, 2007, Pages 1-10

  Yoshida, Mitsuaki A ^a   Nakata, Akifumi ^a,b   Akiyama, Miho ^a   Kakinuma, Shizuko ^b   Sado, Toshihiko ^b   Nishimura, Mayumi ^b   Shimada, Yoshiya ^b  

^a Research Center for Radiation Emergency Medicine   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CANCER MODEL; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 15; CHROMOSOME 19; CHROMOSOME 4; CHROMOSOME DELETION; CHROMOSOME PAINTING; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; HETEROZYGOSITY LOSS; LEUKEMOGENESIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STRUCTURAL CHROMOSOME ABERRATION; THYMUS LYMPHOMA; TRISOMY; TUMOR SUPPRESSOR GENE; X CHROMOSOME; X IRRADIATION;

ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME PAINTING; CHROMOSOMES, MAMMALIAN; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LOSS OF HETEROZYGOSITY; LYMPHOMA; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; THYMUS NEOPLASMS; TRISOMY; X-RAYS;

MUS;

EID: 35548931923     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.06.016     Document Type: Article

References (49)

1. Grabher C., von Boehmer H., and Look A.T. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6 (2006) 347-359
2. Shtivelman E., Lifshitz B., Gale R.P., and Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315 (1985) 550-554
3. Pui C.H., Crist W.M., and Look A.T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76 (1990) 1449-1463
4. Raimondi S.C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81 (1993) 2237-2251
5. Dofuku R., Biedler J.L., Spengler B.A., and Old L.J. Trisomy of chromosome 15 in spontaneous leukemia of AKR mice. Proc Natl Acad Sci USA 72 (1975) 1515-1517
6. Chan F.P., Ball J.K., and Sergovich F.R. Trisomy no. 15 in murine thymomas induced by chemical carcinogens, X-irradiation, and an endogenous murine leukemia virus. J Natl Cancer Inst 62 (1979) 605-610
7. Chan F.P., Ens B., and Frei J.V. Cytogenetics of murine thymic lymphomas induced by N-methyl-N-nitrosourea: difference in incidence of trisomy 15 in thymic lymphomas induced in neonatal and adult mice. Cancer Genet Cytogenet 4 (1981) 337-344
8. Yoshida M.A., Takagi N., and Sasaki M. Influence of strain difference on the karyotypic changes in N-nitroso-N-butylurea-induced mouse lymphomas. Cancer Genet Cytogenet 7 (1982) 19-31
9. McMorrow L.E., Newcomb E.W., and Pellicer A. Identification of a specific marker chromosome early in tumor development in gamma-irradiated C57BL/6J mice. Leukemia 2 (1988) 115-119
10. Knudson Jr. A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68 (1971) 820-823
11. Lasko D., Cavenee W., and Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25 (1991) 281-314
12. Matsumoto Y., Kosugi S., Shinbo T., Chou D., Ohashi M., Wakabayashi Y., Sakai K., Okumoto M., Mori N., Aizawa S., Niwa O., and Kominami R. Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16. Oncogene 16 (1998) 2747-2754
13. Okumoto M., Song C.W., Tabata K., Ishibashi M., Mori N., Park Y.G., Kominami R., Matsumoto Y., Takamori Y., and Esaki K. Putative tumor suppressor gene region within 0.85 cM on chromosome 12 in radiation-induced murine lymphomas. Mol Carcinogen 22 (1998) 175-181
14. Santos J., Herranz M., Pérez de Castro I., Pellicer A., and Fernández-Piqueras J. A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4. Oncogene 17 (1998) 925-929
15. Okumoto M., Park Y.G., Song C.W., and Mori N. Frequent loss of heterozygosity on chromosomes 4, 12 and 19 in radiation-induced lymphomas in mice. Cancer Lett 135 (1999) 223-228
16. Shinbo T., Matsuki A., Matsumoto Y., Kosugi S., Takahashi Y., Niwa O., and Kominami R. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12. Oncogene 18 (1999) 4131-4136
17. Park Y.G., Song C.W., Mori N., Sugimoto K., Hong D.P., and Okumoto M. Analysis of highly frequent allelic loss region on distal chromosome 12 in murine radiation-induced lymphomas. Cancer Lett 148 (2000) 95-103
18. Shimada Y., Nishimura M., Kakinuma S., Okumoto M., Shiroishi T., Clifton K.H., and Wakana S. Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas. Radiat Res 154 (2000) 293-300
19. Shimada Y., Nishimura M., Kakinuma S., Takeuchi T., Ogiu T., Suzuki G., Nakata Y., Sasanuma S., Mita K., and Sado T. Characteristic association between K-ras gene mutation with loss of heterozygosity in X-ray-induced thymic lymphomas of the B6C3F1 mouse. Int J Radiat Biol 77 (2001) 465-473
20. Sato H., Tamura Y., Ochiai Y., Kodama Y., Hatakeyama K., Niwa O., and Kominami R. The D4Mit12 locus on mouse chromosome 4 provides susceptibility to both gamma-ray-induced and N-methyl-N-nitrosourea-induced thymic lymphomas. Cancer Sci 94 (2003) 668-671
21. Kang H.M., Jang J.J., Langford C., Shin S.H., Park S.Y., and Chung Y.J. DNA copy number alterations and expression of relevant genes in mouse thymic lymphomas induced by gamma-irradiation and N-methyl-N-nitrosourea. Cancer Genet Cytogenet 166 (2006) 27-35
22. Zhuang S.M., Schippert A., Haugen-Strano A., Wiseman R.W., and Söderkvist P. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2′,3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Oncogene 16 (1998) 803-808
23. Okano H., Saito Y., Miyazawa T., Shinbo T., Chou D., Kosugi S., Takahashi Y., Odani S., Niwa O., and Kominami R. Homozygous deletions and point mutations of the Ikaros gene in gamma-ray-induced mouse thymic lymphomas. Oncogene 18 (1999) 6677-6683
24. Kakinuma S., Nishimura M., Sasanuma S., Mita K., Suzuki G., Katsura Y., Sado T., and Shimada Y. Spectrum of Znfn1a1 (Ikaros) inactivation and its association with loss of heterozygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice. Radiat Res 157 (2002) 331-340
25. Wakabayashi Y., Inoue J., Takahashi Y., Matsuki A., Kosugi-Okano H., Shinbo T., Mishima Y., Niwa O., and Kominami R. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 301 (2003) 598-603
26. Yoshida M.C., Ikeuchi T., and Sasaki M. Differential staining of parental chromosomes in interspecific cell hybrids with a combined quinacrine and 33258 Hoechst technique. Proc Japan Acad 51 (1975) 184-187
27. Committee on Standardized Genetic Nomenclature for Mice. Standard karyotype of the mouse, Mus musculus. J Hered 63 (1972) 69-72
28. Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci USA 76 (1979) 2442-2446
29. Silva S., Babonits M., Wiener F., and Klein G. Further studies on chromosome 15 trisomy in murine T-cell lymphomas: mapping of the relevant chromosome segment. Int J Cancer 41 (1988) 738-743
30. Liyanage M., Weaver Z., Barlow C., Coleman A., Pankratz D.G., Anderson S., Wynshaw-Boris A., and Ried T. Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood 96 (2000) 1940-1946
31. Sander S., Bullinger L., Karlsson A., Giuriato S., Hernandez-Boussard T., Felsher D.W., and Pollack J.R. Comparative genomic hybridization on mouse cDNA microarrays and its application to a murine lymphoma model. Oncogene 24 (2005) 6101-6107
32. Felsher D.W., and Bishop J.M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4 (1999) 199-207
33. Karlsson Å., Giuriato S., Tang F., Fung-Weier J., Levan G., and Felsher D.W. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. Blood 101 (2003) 2797-2803
34. Weng A.P., Ferrando A.A., Lee W., JPt M., Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., and Aster J.C. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306 (2004) 269-271
35. Sharma V.M., Calvo J.A., Draheim K.M., Cunningham L.A., Hermance N., Beverly L., Krishnamoorthy V., Bhasin M., Capobianco A.J., and Kelliher M.A. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol 26 (2006) 8022-8031
36. Weng A.P., Millholland J.M., Yashiro-Ohtani Y., Arcangeli M.L., Lau A., Wai C., Del Bianco C., Rodriguez C.G., Sai H., Tobias J., Li Y., Wolfe M.S., Shachaf C., Felsher D., Blacklow S.C., Pear W.S., and Aster J.C. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 20 (2006) 2096-2109
37. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., and Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79 (1994) 143-156
38. Sun L., Crotty M.L., Sensel M., Sather H., Navara C., Nachman J., Steinherz P.G., Gaynon P.S., Seibel N., Mao C., Vassilev A., Reaman G.H., and Uckun F.M. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 5 (1999) 2112-2120
39. Nakase K., Ishimaru F., Avitahl N., Dansako H., Matsuo K., Fujii K., Sezaki N., Nakayama H., Yano T., Fukuda S., Imajoh K., Takeuchi M., Miyata A., Hara M., Yasukawa M., Takahashi I., Taguchi H., Matsue K., Nakao S., Niho Y., Takenaka K., Shinagawa K., Ikeda K., Niiya K., and Harada M. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res 60 (2000) 4062-4065
40. Nishii K., Katayama N., Miwa H., Shikami M., Usui E., Masuya M., Araki H., Lorenzo F., Ogawa T., Kyo T., Nasu K., Shiku H., and Kita K. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia. Leukemia 16 (2002) 1285-1292
41. Winandy S., Wu P., and Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83 (1995) 289-299
42. Wang J.H., Nichogiannopoulou A., Wu L., Sun L., Sharpe A.H., Bigby M., and Georgopoulos K. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5 (1996) 537-549
43. Jarošová M., Holzerová M., Jedličková K., Mihál V., Zuna J., Starý J., Pospíšilová D., Zemanová Z., Trka J., Blažek J., Pikalová Z., and Indrák K. Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 123 (2000) 114-122
44. Bertin R., Acquaviva C., Mirebeau D., Guidal-Giroux C., Vilmer E., and Cavé H. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 37 (2003) 44-57
45. Mendoza-Londono R., Kashork C.D., Shaffer L.G., Krance R., and Plon S.E. Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes. Genes Chromosomes Cancer 42 (2005) 82-86
46. Bernard O.A., Busson-LeConiat M., Ballerini P., Mauchauffé M., Della Valle V., Monni R., Nguyen Khac F., Mercher T., Penard-Lacronique V., Pasturaud P., Gressin L., Heilig R., Daniel M.T., Lessard M., and Berger R. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 15 (2001) 1495-1504
47. Bezrookove V., van Zelderen-Bhola S.L., Brink A., Szuhai K., Raap A.K., Barge R., Beverstock G.C., and Rosenberg C. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Cancer Genet Cytogenet 149 (2004) 72-76
48. Przybylski G.K., Dik W.A., Wanzeck J., Grabarczyk P., Majunke S., Martin-Subero J.I., Siebert R., Dolken G., Ludwig W.D., Verhaaf B., van Dongen J.J., Schmidt C.A., and Langerak A.W. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 19 (2005) 201-208
49. Storlazzi C.T., Von Steyern F.V., Domanski H.A., Mandahl N., and Mertens F. Biallelic somatic inactivation of the NF1 gene through chromosomal translocations in a sporadic neurofibroma. Int J Cancer 117 (2005) 1055-1057